ENVB
Enveric Biosciences Inc
NASDAQ · Pharmaceuticals
$2.37
-0.26 (-9.89%)
Open$2.58
Previous Close$2.63
Day High$2.59
Day Low$2.14
52W High$8.54
52W Low$4.07
Volume—
Avg Volume175.2K
Market Cap3.30M
P/E Ratio14.96
EPS$0.52
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+318.1% upside
Current
$2.37
$2.37
Target
$9.91
$9.91
$5.56
$9.91 avg
$13.09
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 985.8K | 1.01M | 1.10M |
| Net Income | 176.3K | 237.2K | 267.5K |
| Profit Margin | 17.9% | 23.5% | 24.3% |
| EBITDA | 315.6K | 375.3K | 375.0K |
| Free Cash Flow | 95.4K | 127.9K | 141.2K |
| Rev Growth | +7.3% | -4.2% | +11.1% |
| Debt/Equity | 0.57 | 0.59 | 0.53 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |